The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).
Related Resources
Case Studies
WORK GROUP TITLE:UDI Capture Work GroupCASE STUDY PARTICIPANTS:
Webcast
An update on current FDA and Congressional activity on independent service for reusable medical devices and the potential impact on your costs and
Webcast
Donna Gammarato discusses the importance of creating specialized value analysis teams to analyze resource utilization and reduce costs
Webcast
Professional Coach Mark Noon discusses the types of skills and actions that a leader needs to create a team-oriented culture.